1. Horan JT, Francis CW (2001) Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation. Semin Thromb Hemost 27:657–666
2. Ratky SM, Martin MJ, Gordon YB, Baker LRI, Leslie J, Chard T (1975) A comparison between radioimmunoassay and other immunological techniques for the measurement of fibrinogen/fibrin degradation products in serum. Brit J of Haematol 30:145–149
3. Cooke ED, Bowcock SA, Pilcher MF, Ibbotson RM, Gordon YB, Sola CM et al (1975) Serum fibrin(ogen) degradation products in diagnosis of deep-vein thrombosis and pulmonary embolism after hip surgery. Lancet 12;2(7924):51–54
4. Clinical and Laboratory Standards Institute (CLSI) (2011) Quantitative D-dimer for the exclusion of venous thromboembolic disease; approved guideline. CLSI document H59-A. CLSI, Wayne
5. Suzuki K, Wada H, Imai H, Iba T, Thachil J, Toh CH; Subcommittee on Disseminated Intravascular Coagulation (2018) A re-evaluation of the D-dimer cut-off value for making a diagnosis according to the ISTH overt-DIC diagnostic criteria: communication from the SSC of the ISTH. J Thromb Haemost 16(7):1442–1444